Trials / Unknown
UnknownNCT04445298
Skin Barrier Assessment in Pregnancy and at Birth
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 160 (estimated)
- Sponsor
- National Jewish Health · Academic / Other
- Sex
- All
- Age
- 0 Minutes – 55 Years
- Healthy volunteers
- Accepted
Summary
This is a prospective birth cohort study assessing the role of maternal and environmental factors on the development of allergic diseases in children. Pregnant mothers will be enrolled and we will examine her skin barrier with skin tape strips (STS) and transepidermal water loss (TEWL), along with blood work. We will then follow her offspring and perform similar testing, along with detailed questionnaires inquiring about exposures such as use of detergents and soaps, sunlight exposure, and pollution exposure. When the infant is around 12 months old, we will contact the family via telephone to see if the child developed any allergic conditions within their first year of life, such as eczema, food allergy, or wheezing. A final questionnaire will be performed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Transepidermal water loss | We will assess the skin with transepidermal water loss (TEWL) by using a condenser-chamber system placed lightly on the skin. This will be performed at baseline, then after every 4 skin tape strips. |
| DIAGNOSTIC_TEST | Skin tape stripping | Adhesive skin sampling discs will be pressed against the skin in a hairless location followed by lifting it free of the skin. The discs will be evaluated for lipid content, protein, and filaggrin byproducts in the collected skin sample. |
| DIAGNOSTIC_TEST | Blood draw | We will draw blood to look at the vitamin D, total immunoglobulin E (IgE), and the filaggrin gene which is important in maintaining the skin barrier. |
| DIAGNOSTIC_TEST | Bacterial PCR swab | Skin swab from the superficial skin will be collected to be assessed in the laboratory via PCR for the presence of staphylococcus aureus. |
Timeline
- Start date
- 2020-08-03
- Primary completion
- 2022-07-01
- Completion
- 2022-07-01
- First posted
- 2020-06-24
- Last updated
- 2020-09-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04445298. Inclusion in this directory is not an endorsement.